AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nivaquine P 250mg Tablet

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Chloroquine (250mg)

Overview Nivaquine P 250mg Tablet

Chloroquine phosphate 250mg tablets combat malaria parasites, preventing and treating the infection. Its mechanism halts parasite proliferation, curbing disease spread. Adhere strictly to your physician's prescribed dosage and duration. Ingestion with food mitigates potential stomach discomfort. Complete the entire treatment course; premature cessation can compromise efficacy and exacerbate adverse reactions. Avoid doubling doses; instead, resume the regimen at the next scheduled time. Employ mosquito control measures: utilize repellents on exposed skin, spray indoor areas, and wear light-colored, protective clothing after dusk. Potential side effects include skin rash, headache, vertigo, and emesis; gastrointestinal distress, anorexia, and nausea may also occur. Persistent side effects warrant medical consultation. Diabetic patients should inform their doctor, monitor blood glucose levels closely due to potential hypoglycemia, and undergo regular eye exams because of potential visual disturbances. Prolonged use necessitates regular blood cell count monitoring. Report unexplained bleeding or bruising, pharyngitis, fever, or fatigue to your doctor immediately.

Uses of Nivaquine P 250mg Tablet

Managing Malaria Infections

Major Benefits of Nivaquine P 250mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nivaquine P 250mg tablets should be administered with a meal.

Common Side effects of Nivaquine P 250mg Tablet:

  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Nivaquine P 250mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nivaquine P 250mg tablets should be administered with a meal.

How Nivaquine P 250mg Tablet works:

Chloroquine phosphate 250mg tablets combat malaria, a parasitic infection. Their mechanism involves elevating blood heme concentrations, a substance lethal to the malaria parasite, thus eliminating the parasite and halting infection progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Nivaquine P 250mg tablets may pose safety risks; physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Nivaquine P 250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactating individuals can generally use Nivaquine P 250mg tablets without safety concerns. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Taking Nivaquine P 250mg Tablets may induce adverse reactions that impair driving ability. These reactions can include blurry vision or difficulty focusing, potentially impacting safe driving.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Nivaquine P 250mg tablets, as dose modification may be necessary. A physician's consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Nivaquine P 250mg Tablets. Dosage modification may be necessary. A physician's consultation is recommended. Routine liver function monitoring during treatment is advisable.

What if you forget to take Nivaquine P 250mg Tablet :

Should you forget a Nivaquine P 250mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nivaquine P 250mg Tablet

LabelValue
Type of Compound Aromatic aminoquinoline compound
Addictive None.
Treatment Category Eye medication.
Mechanism of Action Malaria drugs: Aminoquinoline class

FAQs on Nivaquine P 250mg Tablet

Chloroquine phosphate 250mg tablets are a medication used to treat and prevent malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. However, the onset of symptoms typically ranges from seven to eighteen days post-infection. Early malaria signs mimic influenza, presenting as chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Nivaquine P 250mg Tablets, as directed by your physician, necessitates regular eye examinations. This is a precaution because the chloroquine component may induce blurred vision, reading difficulties (manifesting as apparent word loss), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to commencing treatment with Nivaquine P 250mg Tablets, as it could potentially exacerbate the condition.
Abdominal discomfort, queasiness, emesis, and cephalalgia are among the frequently reported adverse reactions associated with this medication. Ingesting the medication with food may often mitigate these effects.
Insufficient clinical evidence supports the use of chloroquine in COVID-19 treatment. Consequently, self-medicating with Nivaquine P 250mg Tablets for COVID-19 is strongly discouraged without prior physician consultation.
Allow at least four hours between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially received approval as antimalarial drugs. Hydroxychloroquine, however, exhibits a more favorable side effect profile compared to chloroquine. Consequently, hydroxychloroquine enjoys greater current usage. Furthermore, unlike chloroquine, hydroxychloroquine is also an approved treatment for rheumatoid arthritis and lupus.
To avoid malaria, protect yourself from mosquito bites by wearing long sleeves and trousers, using mosquito netting, and applying insect repellent. Consult your physician regarding prophylactic antimalarial medication. If prescribed, adhere strictly to the dosage and complete the entire course of treatment as directed.
Chloroquine phosphate 250mg tablets are employed in the treatment and prophylaxis of malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. The incubation period typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, characterized by chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Patients prescribed Nivaquine P 250mg Tablets for extended durations should undergo regular eye examinations. Prolonged chloroquine use, a component of this medication, can potentially lead to visual blurring, reading difficulties (characterized by apparent word disappearance), and, in rare instances, retinopathy.
Consult your physician about any history of psoriasis prior to commencing treatment with Nivaquine P 250mg Tablets, as it could potentially exacerbate the condition.
Abdominal discomfort, nausea, vomiting, and headache are frequently reported adverse reactions associated with this medication. Ingesting the medication with food may often lessen the severity of these effects.
Insufficient clinical evidence supports the use of chloroquine for COVID-19 treatment. Consequently, it's recommended to avoid self-medicating with Nivaquine P 250mg tablets for this purpose without prior physician consultation.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially gained approval as malaria treatments. Nevertheless, chloroquine is associated with a significantly higher incidence of adverse reactions compared to hydroxychloroquine. Consequently, hydroxychloroquine enjoys greater current usage. Furthermore, unlike chloroquine, hydroxychloroquine holds approval for treating rheumatoid arthritis and lupus.
Mosquito-borne malaria can be avoided through protective measures such as wearing long sleeves and trousers to deter bites, utilizing mosquito nets, and applying insect repellent. Consult your physician regarding the necessity of prophylactic antimalarial medication. If prescribed, adhere strictly to the dosage and complete the entire course of the recommended anti-malarial drug.
Nivaquine P 250mg Tablet
6
MRP 8
22% off